Eterna Therapeutics (ERNA) Q1 2025 Earnings
ERNA·Reported May 7, 2025·Before market open
Diluted EPS came in at $-2.25 (-82.9% YoY).
Diluted EPS
$-2.25
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Eterna Therapeutics's Q1 2025 earnings report.
Eterna Therapeutics (ERNA) reported Q1 2025 earnings on May 7, 2025 before market open.
Eterna Therapeutics reported diluted EPS of $-2.25 for Q1 2025.
Compared to the same quarter a year prior, diluted EPS declined 82.9% from $-1.23.
You can read the 10-Q periodic report (0001641172-25-009044) directly on SEC EDGAR. The filing index links above go to sec.gov.